Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fixed-dose alpha lipoic acid + vitamin B combination for diabetic polyneuropathy in type 2 diabetes mellitus
TCTR20250608002Phase 3Completed
- Sponsor
- Brego Life Sciences
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Bionerv in diabetic polyneuropathy (DPN), type 2 diabetes mellitus (T2DM), sponsored by Brego Life Sciences. Started Jun 2024; status: completed.
02
Drugs
Bionerv
03
Conditions
diabetic polyneuropathy (DPN)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20250608002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250608002.